Breathing-Controlled Electrical Stimulation Tested for Hand Recovery After Stroke
Tests a breathing-controlled electrical stimulation device in adults with chronic stroke and hand weakness.
Plain-language title generated from the registry record
Registry title: BreEStim for Post-Stroke Motor Recovery
Key facts
- Where
- Houston, United StatesSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Source: NCT04750551, who can take part
Where in United States
- The University of Texas Health Science CenterHouston, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- The University of Texas Health Science Center, Houston
- Trial code
- NCT04750551
- Record updated
- 3 June 2026
- Original description
The overall goal is to investigate the effectiveness of a novel intervention - Breathing-controlled electrical stimulation (BreEStim) on finger flexor spasticity reduction and hand function improvement in chronic stroke with moderate impairment.Read full original descriptionShow less
BreEStim for Motor Recovery in Chronic Stroke With Moderate Impairment (Pilot).
The overall goal is to investigate the effectiveness of a novel intervention - Breathing-controlled electrical stimulation (BreEStim) on finger flexor spasticity reduction and hand function improvement in chronic stroke with moderate impairment.
Inclusion: has post stroke ≥ 6 months , medically stable; Unilateral, single stroke (no restriction on type (ischemic or hemorrhagic) or volume (large or small) of stroke); MAS score ≥ 1, i.e., detectable finger flexor hypertonia.
Exclusion: Patients that are currently adjusting tone alternating medications (e.g., baclofen), or; Patients received botulinum toxin injection to the arm/fingers <4 months, or phenol injections < 2 years; Patients with visual deficit/neglect; hearing or cognitive impairment; Patients with history of pulmonary disease (Asthma, chronic obstruction pulmonary disease, COPD); Patients with a pacemaker; Women who are pregnant.